PCN57 Budget IMPACT Analysis of Trifluridine/Tipiracil (FTD/TPI) As a Third-LINE Treatment of Metastatic Gastric Cancer, Including Adenocarcinoma of the Gastroesophageal Junction, Among Patients WHO Have Received at Least Two PRIOR Therapies for Metastatic Disease in Greece

Autor:	P. Papakotoulas, M. Koulentaki, G Gourzoulidis, Georgia Kourlaba, N. Androulakis, M. Karamouzis, Anna Koumarianou, E. Samantas, V. Chotzagiannoglou, I. Boukovinas, Alexandra Beletsi, S. Xynogalos, I Souglakos
Rok vydání:	2020
Předmět:	Oncology medicine.medical_specialty business.industry Health Policy Public Health Environmental and Occupational Health Disease Budget impact medicine.disease Gastroesophageal Junction Metastatic gastric cancer Internal medicine Medicine Adenocarcinoma business Third line treatment
Zdroj:	Value in Health. 23:S431-S432
ISSN:	1098-3015
DOI:	10.1016/j.jval.2020.08.194
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::fc5185200f76ecf46baf61dff8717b43 https://doi.org/10.1016/j.jval.2020.08.194 Zobrazit plný text záznamu Full Text from ScienceDirect